Yu-Waye Chu's Net Worth

$1.44 Million

Estimate Recalculated Feb 10, 2025 11:00PM EST

Who is Yu-Waye Chu

Yu-Waye Chu has an estimated net worth of $1.44 Million. This is based on reported shares across multiple companies, which include FATE THERAPEUTICS INC, and CytomX Therapeutics, Inc..

SEC CIK

Yu-Waye Chu's CIK is 0001854586

Past Insider Trading and Trends

2024 was Yu-Waye Chu's most active year for acquiring shares with 3 total transactions. Yu-Waye Chu's most active month to acquire stocks was the month of December. 2021 was Yu-Waye Chu's most active year for disposing of shares, totalling 11 transactions. Yu-Waye Chu's most active month to dispose stocks was the month of November. 2021 saw Yu-Waye Chu paying a total of $122,400.00 for 68,458 shares, this is the most they've acquired in one year. In 2022 Yu-Waye Chu cashed out on 8,027 shares for a total of $336,013.42, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FATE THERAPEUTICS INC

Chief Medical Officer
Updated Apr 19, 2023
Form 4
-1.77%
-2.53K
$6.57
-$16.65K
Apr 19, 2023
140.68K
Sale
Apr 18
Form 4
425.00K
Feb 07, 2023
425.00K
Grant
Feb 06
Form 4
-5.18%
-7.83K
$5.24
-$41.00K
Jan 11, 2023
143.21K
Sale
Jan 10
Form 4
-2.62%
-4.06K
$35.37
-$143.67K
Apr 21, 2022
151.03K
Sale
Apr 19
Form 4
70.91%
86.36K
Jan 27, 2022
208.15K
Grant
Jan 25
Form 4
-3.15%
-3.96K
$48.51
-$192.34K
Jan 13, 2022
121.79K
Sale
Jan 11
Form 4
-1.53%
-7.50K
$35.05
-$263.55K
Dec 13, 2021
483.88K
Sale
ScheduledDec 10
Form 4
94.07%
60.96K
Nov 22, 2021
125.76K
Grant
Nov 19
Form 4
-4.81%
-3.27K
$83.30
-$272.81K
Apr 20, 2021
64.80K
Sale
Apr 16
Form 3
Apr 02, 2021
68.08K
Showing 10 results

CytomX Therapeutics, Inc.

Chief Medical Officer
Updated Jan 19, 2024
Form 4
223.75K
Jan 19, 2024
223.75K
Grant
Jan 18
Form 4
375.00K
Jul 20, 2023
375.00K
Grant
Jul 19
Form 3
Jul 20, 2023
Showing 3 results